Skip to main content

Advertisement

SpringerLink
Log in

Progress towards the integration of pharmacogenomics in practice

  • Review Paper
  • Published:
Human Genetics Aims and scope Submit manuscript

Abstract

Understanding the role genes and genetic variants play in clinical treatment response continues to be an active area of research with the goal of common clinical use. This goal has developed into today’s industry of pharmacogenomics, where new drug-gene relationships are discovered and further characterized, published and then curated into national and international resources for use by researchers and clinicians. These efforts have given us insight into what a pharmacogenomic variant is, and how it differs from human disease variants and common polymorphisms. While publications continue to reveal pharmacogenomic relationships between genes and specific classes of drugs, many challenges remain toward the goal of widespread use clinically. First, the clinical guidelines for pharmacogenomic testing are still in their infancy. Second, sequencing technologies are changing rapidly making it somewhat unclear what genetic data will be available to the clinician at the time of care. Finally, what and when to return data to a patient is an area under constant debate. New innovations such as PheWAS approaches and whole genome sequencing studies are enabling a tsunami of new findings. In this review, pharmacogenomic variants, pharmacogenomic resources, interpretation clinical guidelines and challenges, such as WGS approaches, and the impact of pharmacogenomics on drug development and regulatory approval are reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • (FDA), T. F. a. D. A. (2013) “Clinical pharmacogenomics: premarket evaluation in early-phase clinical studies and Recommendations for labeling.” from http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM337169.pdf

  • Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet Chapter 7: Unit7 20

  • Allison M (2010) Genetic testing clamp down. Nat Biotechnol 28(7):633

    Article  CAS  PubMed  Google Scholar 

  • Ardlie KG, Kruglyak L, Seielstad M (2002) Patterns of linkage disequilibrium in the human genome. Nat Rev Genet 3(4):299–309

    Article  CAS  PubMed  Google Scholar 

  • Ashley EA, Butte AJ, Wheeler MT, Chen R, Klein TE, Dewey FE, Dudley JT, Ormond KE, Pavlovic A, Morgan AA, Pushkarev D, Neff NF, Hudgins L, Gong L, Hodges LM, Berlin DS, Thorn CF, Sangkuhl K, Hebert JM, Woon M, Sagreiya H, Whaley R, Knowles JW, Chou MF, Thakuria JV, Rosenbaum AM, Zaranek AW, Church GM, Greely HT, Quake SR, Altman RB (2010) Clinical assessment incorporating a personal genome. Lancet 375(9725):1525–1535

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Booth RA, Ansari MT, Loit E, Tricco AC, Weeks L, Doucette S, Skidmore B, Sears M, Sy R, Karsh J (2011) Assessment of thiopurine S-methyltransferase activity in patients prescribed thiopurines: a systematic review. Ann Intern Med 154(12):814–823 W-295-818

    Article  PubMed  Google Scholar 

  • Brauch H, Schwab M (2014) Prediction of tamoxifen outcome by genetic variation of CYP2D6 in post-menopausal women with early breast cancer. Br J Clin Pharmacol 77(4):695–703

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Brooksbank C, Bergman MT, Apweiler R, Birney E, Thornton J (2014) The European Bioinformatics Institute’s data resources 2014. Nucleic Acids Res 42(Database issue):D18–D25

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Crowley JJ, Sullivan PF, McLeod HL (2009) Pharmacogenomic genome-wide association studies: lessons learned thus far. Pharmacogenomics 10(2):161–163

    Article  PubMed Central  PubMed  Google Scholar 

  • Daly AK (2010) Genome-wide association studies in pharmacogenomics. Nat Rev Genet 11(4):241–246

    Article  CAS  PubMed  Google Scholar 

  • Daly AK (2012) Using genome-wide association studies to identify genes important in serious adverse drug reactions. Annu Rev Pharmacol Toxicol 52:21–35

    Article  CAS  PubMed  Google Scholar 

  • Denny JC, Ritchie MD, Basford MA, Pulley JM, Bastarache L, Brown-Gentry K, Wang D, Masys DR, Roden DM, Crawford DC (2010) PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics 26(9):1205–1210

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Denny JC, Bastarache L, Ritchie MD, Carroll RJ, Zink R, Mosley JD, Field JR, Pulley JM, Ramirez AH, Bowton E, Basford MA, Carrell DS, Peissig PL, Kho AN, Pacheco JA, Rasmussen LV, Crosslin DR, Crane PK, Pathak J, Bielinski SJ, Pendergrass SA, Xu H, Hindorff LA, Li R, Manolio TA, Chute CG, Chisholm RL, Larson EB, Jarvik GP, Brilliant MH, McCarty CA, Kullo IJ, Haines JL, Crawford DC, Masys DR, Roden DM (2013) Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat Biotechnol 31(12):1102–1110

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Dewey FE, Grove ME, Pan C, Goldstein BA, Bernstein JA, Chaib H, Merker JD, Goldfeder RL, Enns GM, David SP, Pakdaman N, Ormond KE, Caleshu C, Kingham K, Klein TE, Whirl-Carrillo M, Sakamoto K, Wheeler MT, Butte AJ, Ford JM, Boxer L, Ioannidis JP, Yeung AC, Altman RB, Assimes TL, Snyder M, Ashley EA, Quertermous T (2014) Clinical interpretation and implications of whole-genome sequencing. JAMA 311(10):1035–1045

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Eichelbaum M (2013) Pharmacogenetics: current state after 30 years of research. Dtsch Med Wochenschr 138(13):659–661

    Article  CAS  PubMed  Google Scholar 

  • Eichelbaum M, Ingelman-Sundberg M, Evans WE (2006) Pharmacogenomics and individualized drug therapy. Annu Rev Med 57:119–137

    Article  CAS  PubMed  Google Scholar 

  • Evans WE, McLeod HL (2003) Pharmacogenomics—drug disposition, drug targets, and side effects. N Engl J Med 348(6):538–549

    Article  CAS  PubMed  Google Scholar 

  • Garten Y, Tatonetti NP, Altman RB (2010) Improving the prediction of pharmacogenes using text-derived drug-gene relationships. Pac Symp Biocomput: 305–314

  • Gharani N, Keller MA, Stack CB, Hodges LM, Schmidlen TJ, Lynch DE, Gordon ES, Christman MF (2013) The Coriell personalized medicine collaborative pharmacogenomics appraisal, evidence scoring and interpretation system. Genome Med 5(10):93

    Article  PubMed Central  PubMed  Google Scholar 

  • Giacomini KM, Brett CM, Altman RB, Benowitz NL, Dolan ME, Flockhart DA, Johnson JA, Hayes DF, Klein T, Krauss RM, Kroetz DL, McLeod HL, Nguyen AT, Ratain MJ, Relling MV, Reus V, Roden DM, Schaefer CA, Shuldiner AR, Skaar T, Tantisira K, Tyndale RF, Wang L, Weinshilboum RM, Weiss ST, Zineh I, Pharmacogenetics Research Network (2007) The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther 81(3):328–345

    Article  CAS  PubMed  Google Scholar 

  • Gisbert JP, Gomollon F (2008) Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol 103(5):1299–1307

    Article  PubMed  Google Scholar 

  • Glubb DM, Paugh SW, van Schaik RH, Innocenti F (2013) A guide to the current Web-based resources in pharmacogenomics. Methods Mol Biol 1015:293–310

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Gordon AS, Smith JD, Xiang Q, Metzker ML, Gibbs RA, Mardis ER, Nickerson DA, Fulton RS, Scherer SE (2012). PGRNseq: a new sequencing-based platform for high-throughput pharmacogenomic implementation and discovery. American Society of Human Genetics (ASHG) Annual Meeting, Session 46. Pharmacogenetics: from discovery to implementation, Boston, USA

  • Guo Y, Weller P, Farrell E, Cheung P, Fitch B, Clark D, Wu SY, Wang J, Liao G, Zhang Z, Allard J, Cheng J, Nguyen A, Jiang S, Shafer S, Usuka J, Masjedizadeh M, Peltz G (2006) In silico pharmacogenetics of warfarin metabolism. Nat Biotechnol 24(5):531–536

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Guo Y, Lu P, Farrell E, Zhang X, Weller P, Monshouwer M, Wang J, Liao G, Zhang Z, Hu S, Allard J, Shafer S, Usuka J, Peltz G (2007) In silico and in vitro pharmacogenetic analysis in mice. Proc Natl Acad Sci USA 104(45):17735–17740

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Hoskins JM, Marcuello E, Altes A, Marsh S, Maxwell T, Van Booven DJ, Paré L, Culverhouse R, McLeod HL, Baiget M (2008) Irinotecan pharmacogenetics: influence of pharmacodynamic genes. Clin Cancer Res 14(6):1788–1796

    Article  CAS  PubMed  Google Scholar 

  • Huang RS, Gamazon ER (2013) Translating pharmacogenomics discoveries into the clinic: an implementation framework. Genome Med 5(10):94

    Article  PubMed Central  PubMed  Google Scholar 

  • Ingelman-Sundberg M (2005) Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J 5(1):6–13

    Article  CAS  PubMed  Google Scholar 

  • Johnson JA, Gong L, Whirl-Carrillo M, Gage BF, Scott SA, Stein CM, Anderson JL, Kimmel SE, Lee MT, Pirmohamed M, Wadelius M, Klein TE, Altman RB, Clinical Pharmacogenetics Implementation Consortium (2011) Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther 90(4):625–629

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Johnson JA, Burkley BM, Langaee TY, Clare-Salzler MJ, Klein TE, Altman RB (2012) Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array. Clin Pharmacol Ther 92(4):437–439

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, Rosenberg YD, Eby CS, Madigan RA, McBane RB, Abdel-Rahman SZ, Stevens SM, Yale S, Mohler ER 3rd, Fang MC, Shah V, Horenstein RB, Limdi NA, Muldowney JA 3rd, Gujral J, Delafontaine P, Desnick RJ, Ortel TL, Billett HH, Pendleton RC, Geller NL, Halperin JL, Goldhaber SZ, Caldwell MD, Califf RM, Ellenberg JH, Investigators C (2013) A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med 369(24):2283–2293

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Klein DJ, Thorn CF, Desta Z, Flockhart DA, Altman RB, Klein TE (2013) PharmGKB summary: tamoxifen pathway, pharmacokinetics. Pharmacogenet Genomics 23(11):643–647

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, Maglott DR (2014) ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res 42(Database issue):D980–D985

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Lee MT, Klein TE (2013) Pharmacogenetics of warfarin: challenges and opportunities. J Hum Genet 58(6):334–338

    Article  CAS  PubMed  Google Scholar 

  • Li B, Seligman C, Thusberg J, Miller JL, Auer J, Whirl-Carrillo M, Capriotti E, Klein TE, Mooney SD (2014) In silico comparative characterization of pharmacogenomic missense variants. BMC Genomics 15(Suppl 4):S4

  • Li B, Krishnan VG, Mort ME, Xin F, Kamati KK, Cooper DN, Mooney SD, Radivojac P (2009) Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics 25(21):2744–2750

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Li-Wan-Po A, Girard T, Farndon P, Cooley C, Lithgow J (2010) Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17. Br J Clin Pharmacol 69(3):222–230

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • McCarty CA, Chisholm RL, Chute CG, Kullo IJ, Jarvik GP, Larson EB, Li R, Masys DR, Ritchie MD, Roden DM, Struewing JP, Wolf WA, eMERGE Team (2011) The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics 4:13

    Article  PubMed Central  PubMed  Google Scholar 

  • McLeod HL (2013) Cancer pharmacogenomics: early promise, but concerted effort needed. Science 339(6127):1563–1566

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Mort M, Sterne-Weiler T, Li B, Ball EV, Cooper DN, Radivojac P, Sanford JR, Mooney SD (2014) MutPred Splice: machine learning-based prediction of exonic variants that disrupt splicing. Genome Biol 15(1):R19

    Article  PubMed Central  PubMed  Google Scholar 

  • Motsinger-Reif AA, Jorgenson E, Relling MV, Kroetz DL, Weinshilboum R, Cox NJ, Roden DM (2013) Genome-wide association studies in pharmacogenomics: successes and lessons. Pharmacogenet Genomics 23(8):383–394

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Nebert DW (1999) Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist? Clin Genet 56(4):247–258

    Article  CAS  PubMed  Google Scholar 

  • Neuraz A, Chouchana L, Malamut G, Le Beller C, Roche D, Beaune P, Degoulet P, Burgun A, Loriot MA, Avillach P (2013) Phenome-wide association studies on a quantitative trait: application to TPMT enzyme activity and thiopurine therapy in pharmacogenomics. PLoS Comput Biol 9(12):e1003405

    Article  PubMed Central  PubMed  Google Scholar 

  • Oetting WS, Robinson PN, Greenblatt MS, Cotton RG, Beck T, Carey JC, Doelken SC, Girdea M, Groza T, Hamilton CM, Hamosh A, Kerner B, MacArthur JA, Maglott DR, Mons B, Rehm HL, Schofield PN, Searle BA, Smedley D, Smith CL, Bernstein IT, Zankl A, Zhao EY (2013) Getting ready for the Human Phenome Project: the 2012 forum of the Human Variome Project. Hum Mutat 34(4):661–666

    PubMed Central  PubMed  Google Scholar 

  • Ormond KE, Wheeler MT, Hudgins L, Klein TE, Butte AJ, Altman RB, Ashley EA, Greely HT (2010) Challenges in the clinical application of whole-genome sequencing. Lancet 375(9727):1749–1751

    Article  PubMed  Google Scholar 

  • Owen RP, Altman RB, Klein TE (2008) PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics. Hum Mutat 29(4):456–460

    Article  CAS  PubMed  Google Scholar 

  • Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W (2001) Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA 286(18):2270–2279

    Article  CAS  PubMed  Google Scholar 

  • Pirmohamed M, Burnside G, Eriksson N, Jorgensen AL, Toh CH, Nicholson T, Kesteven P, Christersson C, Wahlstrom B, Stafberg C, Zhang JE, Leathart JB, Kohnke H, Maitland-van der Zee AH, Williamson PR, Daly AK, Avery P, Kamali F, Wadelius M, E.-P. Group (2013) A randomized trial of genotype-guided dosing of warfarin. N Engl J Med 369(24):2294–2303

    Article  CAS  PubMed  Google Scholar 

  • Price MJ, Carson AR, Murray SS, Phillips T, Janel L, Tisch R, Topol E, Levy S (2012) First pharmacogenomic analysis using whole exome sequencing to identify novel genetic determinants of clopidogrel response variability: results of the genotype information and functional testing (gift) exome study. J Am Coll Cardiol 59(13s1):E9

    Article  Google Scholar 

  • Pulley JM, Denny JC, Peterson JF, Bernard GR, Vnencak-Jones CL, Ramirez AH, Delaney JT, Bowton E, Brothers K, Johnson K, Crawford DC, Schildcrout J, Masys DR, Dilks HH, Wilke RA, Clayton EW, Shultz E, Laposata M, McPherson J, Jirjis JN, Roden DM (2012) Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project. Clin Pharmacol Ther 92(1):87–95

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Ramos EM, Din-Lovinescu C, Berg JS, Brooks LD, Duncanson A, Dunn M, Good P, Hubbard TJ, Jarvik GP, O’Donnell C, Sherry ST, Aronson N, Biesecker LG, Blumberg B, Calonge N, Colhoun HM, Epstein RS, Flicek P, Gordon ES, Green ED, Green RC, Hurles M, Kawamoto K, Knaus W, Ledbetter DH, Levy HP, Lyon E, Maglott D, McLeod HL, Rahman N, Randhawa G, Wicklund C, Manolio TA, Chisholm RL, Williams MS (2014) Characterizing genetic variants for clinical action. Am J Med Genet C Semin Med Genet 166(1):93–104

    Article  Google Scholar 

  • Relling MV, Klein TE (2011) CPIC: clinical Pharmacogenetics Implementation Consortium of the pharmacogenomics research network. Clin Pharmacol Ther 89(3):464–467

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Ritchie MD (2012) The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era. Hum Genet 131(10):1615–1626

    Article  PubMed Central  PubMed  Google Scholar 

  • Ritchie GR, Dunham I, Zeggini E, Flicek P (2014) Functional annotation of noncoding sequence variants. Nat Methods 11(3):294–296

    Article  CAS  PubMed  Google Scholar 

  • Ross CJ, Visscher H, Sistonen J, Brunham LR, Pussegoda K, Loo TT, Rieder MJ, Koren G, Carleton BC, Hayden MR, C. Consortium (2010) The Canadian Pharmacogenomics Network for drug safety: a model for safety pharmacology. Thyroid 20(7):681–687

    Article  CAS  PubMed  Google Scholar 

  • Scott SA (2013) Clinical pharmacogenomics: opportunities and challenges at point of care. Clin Pharmacol Ther 93(1):33–35

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Sheridan C (2014) Milestone approval lifts Illumina’s NGS from research into clinic. Nat Biotechnol 32(2):111–112

    Article  CAS  PubMed  Google Scholar 

  • Stenson PD, Ball EV, Mort M, Phillips AD, Shaw K, Cooper DN (2012) The Human Gene Mutation Database (HGMD) and its exploitation in the fields of personalized genomics and molecular evolution. Curr Protoc Bioinformat Chapter 1: Unit1 13

  • Stergiopoulos K, Brown DL (2014) Genotype-guided vs clinical dosing of warfarin and its analogues: meta-analysis of randomized clinical trials. JAMA Intern Med 174(8):1330–1338

    Article  CAS  PubMed  Google Scholar 

  • Sturm AC, Sweet K, Manickam K (2013) Implementation of a clinical research pharmacogenomics program at an academic medical center: role of the genetics healthcare professional. Pharmacogenomics 14(7):703–706

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Swen JJ, Nijenhuis M, de Boer A, Grandia L, Maitland-van der Zee AH, Mulder H, Rongen GA, van Schaik RH, Schalekamp T, Touw DJ, van der Weide J, Wilffert B, Deneer VH, Guchelaar HJ (2011) Pharmacogenetics: from bench to byte—an update of guidelines. Clin Pharmacol Ther 89(5):662–673

    Article  CAS  PubMed  Google Scholar 

  • Thorn CF, Klein TE, Altman RB (2013) PharmGKB: the pharmacogenomics knowledge base. Methods Mol Biol 1015:311–320

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Verhoef TI, Ragia G, de Boer A, Barallon R, Kolovou G, Kolovou V, Konstantinides S, Le Cessie S, Maltezos E, van der Meer FJ, Redekop WK, Remkes M, Rosendaal FR, van Schie RM, Tavridou A, Tziakas D, Wadelius M, Manolopoulos VG, Maitland-van der Zee AH, E.-P. Group (2013) A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon. N Engl J Med 369(24):2304–2312

    Article  CAS  PubMed  Google Scholar 

  • Wang L, Weinshilboum RM (2008) Pharmacogenomics: candidate gene identification, functional validation and mechanisms. Hum Mol Genet 17(R2):R174–R179

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Wheeler HE, Maitland ML, Dolan ME, Cox NJ, Ratain MJ (2013) Cancer pharmacogenomics: strategies and challenges. Nat Rev Genet 14(1):23–34

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Zhao Y, Clark WT, Mort M, Cooper DN, Radivojac P, Mooney SD (2011) Prediction of functional regulatory SNPs in monogenic and complex disease. Hum Mutat 32(10):1183–1190

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Zineh I, Pacanowski MA (2011) Pharmacogenomics in the assessment of therapeutic risks versus benefits: inside the United States Food and Drug Administration. Pharmacotherapy 31(8):729–735

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

SDM is funded by NIH R01 LM009722 (PI:Mooney) and the Buck Trust.

Author information

Authors and Affiliations

  1. Buck Institute for Research on Aging, 8001 Redwood Blvd, Novato, CA, 94945, USA

    Sean D. Mooney

Authors
  1. Sean D. Mooney
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sean D. Mooney.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mooney, S.D. Progress towards the integration of pharmacogenomics in practice. Hum Genet 134, 459–465 (2015). https://doi.org/10.1007/s00439-014-1484-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00439-014-1484-7

Keywords

Search

Navigation